- Home
- YETI vs CLDX Comparison
YETI vs CLDX Comparison
Compare YETI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YETI | CLDX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | YETI | CLDX |
|---|---|---|
| Price | $42.66 | $30.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 15 |
| Target Price | $54.06 | ★ $64.00 |
| AVG Volume (30 Days) | ★ 1.3M | 974.3K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $1,868,494,000.00 | $12,743,000.00 |
| Revenue This Year | $7.59 | $2.93 |
| Revenue Next Year | $7.09 | $485.55 |
| P/E Ratio | $42.26 | ★ N/A |
| Revenue Growth | 2.11 | ★ 87.78 |
| 52 Week Low | $34.90 | $22.33 |
| 52 Week High | $53.99 | $45.14 |
Technical Indicators
Market Signals| Indicator | YETI | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 49.03 |
| Support Level | $38.74 | $28.34 |
| Resistance Level | $43.39 | $31.83 |
| Average True Range (ATR) | 1.62 | 1.41 |
| MACD | -0.07 | 0.37 |
| Stochastic Oscillator | 5.33 | 63.62 |
Price Performance
Historical ComparisonAbout YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.